Streetbeat News

Earnings

NCNO

Ncino (NASDAQ:NCNO) reported Q4 adjusted EPS of $0.21, surpassing the $0.12 estimate, marking a 425% increase from last year. However, its sales of $123.69M fell short of the $124.62M estimate, though they were up 13.29% from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 8:11 pm

CNXC

Concentrix (CNXC) provided its Q2 and FY24 earnings guidance, with both EPS and revenue forecasts slightly below analyst estimates. The company anticipates a negative impact from foreign exchange rates but expects constant currency revenue growth of 1% to 3%. Operating income and non-GAAP operating income are also projected within specific ranges. Additionally, Concentrix plans to repurchase $100 million of its common stock during the final three quarters of fiscal 2024. The company noted challenges in providing a quantitative reconciliation of non-GAAP EPS to GAAP measures due to uncertainties in future acquisition contingent considerations and foreign currency fluctuations.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 8:11 pm

APTO

Aptose Biosciences (NASDAQ:APTO) reported Q4 earnings, beating estimates by 9.0% with an EPS of $-1.44 against an expected $-1.59. However, revenue remained unchanged from the previous year. Despite beating last quarter's EPS estimates, the share price dropped by 24.0% the following day.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 8:10 pm

VNCE

Vince Holding announced it is on track to meet its profitability objectives for the full year 2023, with the final financial results for Q4 and the full year expected by late April 2024.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 8:09 pm

CNXC

Concentrix (NASDAQ:CNXC) reported Q1 earnings of $2.57 per share, slightly missing the consensus estimate of $2.58. However, their quarterly sales of $2.40 billion exceeded the expected $2.38 billion, marking a significant 46.83% increase from the previous year.

Portfolio Pulse from Happy Mohamed

March 26, 2024 | 8:08 pm

GME

GameStop reported Q4 2024 adjusted earnings per share (EPS) of $0.22, missing the consensus estimate of $0.29 by 24.14%. Quarterly sales were $1.794 billion, below the consensus estimate of $2.050 billion by 12.47%.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 8:07 pm

APTO

Aptose Biosciences reported a fiscal year 2023 loss per share of $(7.58), compared to a loss of $(6.80) per share in the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 8:06 pm

GME

GameStop reported Q4 earnings of $0.21 per share, missing the consensus estimate of $0.25 by 16%. Quarterly sales were $1.794 billion, missing the estimate of $2.050 billion by 12.47%.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 8:06 pm

MRAI

Marpai (NASDAQ:MRAI) reported a Q4 EPS loss of $(0.65), a 60.37% improvement from last year's $(1.64) loss. Quarterly sales were $8.71M, meeting analyst expectations and marking a 14.18% increase from the previous year.

Portfolio Pulse from Happy Mohamed

March 26, 2024 | 8:03 pm

WDS

Woodside Energy Group Inc. (NYSE:WDS) saw a slight increase of 0.51% in its stock price to $19.80 in the current market session. Despite this, the stock has experienced a decline of 1.26% over the past month and 12.78% over the past year. The company's P/E ratio of 22.67, compared to the industry average of 12.16, suggests it may be overvalued or expected to outperform the Oil, Gas & Consumable Fuels industry.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 8:00 pm